News for 'Food and Drugs Administration'

SPARC shares surge 15%; m-cap up by Rs 1,685 cr

SPARC shares surge 15%; m-cap up by Rs 1,685 cr

Rediff.com9 Mar 2015

The company's market value rose by Rs 1,684.87 crore.

Wockhardt gets import alert from US FDA

Wockhardt gets import alert from US FDA

Rediff.com6 Aug 2016

Ankleshwar plant is the third such facility to face action

Oxford jabs effective against severe Covid: US trial

Oxford jabs effective against severe Covid: US trial

Rediff.com22 Mar 2021

The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.

FIR filed against Snapdeal CEO, directors

FIR filed against Snapdeal CEO, directors

Rediff.com1 May 2015

In April, Snapdeal had said it was delisting the drugs from its portal and was assisting the regulator in the investigation.

PE/VC investments in pharma cos cross $1 bn mark

PE/VC investments in pharma cos cross $1 bn mark

Rediff.com6 Oct 2020

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.

Maha portfolios: Sena gets home, NCP finance, Cong revenue

Maha portfolios: Sena gets home, NCP finance, Cong revenue

Rediff.com13 Dec 2019

Portfolios were distributed 2 weeks after the MVA govt was sworn-in. Shiv Sena's Eknath Shinde will be home minister while NCP's Jayant Patil will be finance minister.

WHO clears Serum Institute's Covovax for emergency use

WHO clears Serum Institute's Covovax for emergency use

Rediff.com18 Dec 2021

'WHO issued an emergency use listing for Covovax, expanding the basket of WHO-validated vaccines against COVID-19. The vaccine is produced by the Serum Institute of India under licence from Novavax,' the world health body said in a tweet on Friday.

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Rediff.com27 Jun 2014

Ohm Laboratories Inc, a wholly-owned subsidiary of Ranbaxy has received approval from the US Food and Drug Administration for manufacturing and marketing Valsartan tablets in strengths of 40 mg, 80 mg, 160 mg, and 320 mg on an exclusive basis, Ranbaxy Laboratories said in a statement.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Covishield accounts for 88% of Covid jabs in India

Covishield accounts for 88% of Covid jabs in India

Rediff.com1 Jan 2022

Serum Institute has the capacity to make 250 million doses of Covishield monthly.

'Famotidine may become the next HCQ for Covid-19'

'Famotidine may become the next HCQ for Covid-19'

Rediff.com10 May 2020

Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its clinical trials, it led to a drug shortage in the US. Back home, however, there has not been any surge in the demand for Famotidine yet.

Indian regulator also scans Ranbaxy

Indian regulator also scans Ranbaxy

Rediff.com20 Sep 2013

The move comes in the wake of many facilities of Ranbaxy in India being barred by the US Food and Drugs Administration for supplying medicines to the US.

US warns Novartis on manufacturing violations at 2 India plants

US warns Novartis on manufacturing violations at 2 India plants

Rediff.com28 Oct 2015

US firm Mylan NV received a stern warning from the FDA in August for faulty manufacturing practices at three of its India drugmaking plants.

Ranbaxy stock nosedives 20% on USFDA restrictions

Ranbaxy stock nosedives 20% on USFDA restrictions

Rediff.com24 Jan 2014

Shares of Ranbaxy Laboratories on Friday slumped as much as 20 per cent in the morning trade after the USFDA prohibited the company from producing and distributing drugs for the American market from its Toansa plant in Punjab.

We will prevail: Trump hints at 2024 presidential bid

We will prevail: Trump hints at 2024 presidential bid

Rediff.com1 Mar 2021

Speaking at the Conservative Political Action Committee in Orlando, Florida on Sunday, the 74-year-old leader, who left the White House on January 20, stopped short of announcing to run for the president in 2024, although he gave enough indications that he is moving in that direction.

Dilip Shanghvi's success: From a start-up to India's largest drug maker

Dilip Shanghvi's success: From a start-up to India's largest drug maker

Rediff.com11 Mar 2015

Dilip Shanghvi founded Sun Pharma in 1983.

India lifts temporary ban on supply of hydroxychloroquine

India lifts temporary ban on supply of hydroxychloroquine

Rediff.com7 Apr 2020

India on Tuesday temporarily licensed the export of paracetamol and anti-malarial drug Hydroxychloroquine in appropriate quantities to some countries, which have been particularly badly affected by the coronavirus pandemic.

US FDA conducts surprise inspection of Dr Reddy's Vizag plant

US FDA conducts surprise inspection of Dr Reddy's Vizag plant

Rediff.com20 Nov 2014

The FDA has been tightening its monitoring of Indian pharma majors over compliance issues. Surprise plant inspections and import alerts have been frequent outcomes

Pfizer withheld Covid vaccine news before elections: Trump

Pfizer withheld Covid vaccine news before elections: Trump

Rediff.com10 Nov 2020

Trump had said that he worked on removing a large number of bureaucratic obstacles to fast-track development and approval of a vaccine.

US regulator urges USV to probe staff for inaccurate data reporting

US regulator urges USV to probe staff for inaccurate data reporting

Rediff.com5 Mar 2014

The US Food and Drug Administration has asked USV to probe employees who might have been responsible for inaccurate data reporting.

Karnataka, Gujarat lift ban on Maggi

Karnataka, Gujarat lift ban on Maggi

Rediff.com19 Oct 2015

The state government had in the first week of June banned Maggi sale in the state after the product failed the food safety test.

US lifts mask guidance for fully vaccinated people

US lifts mask guidance for fully vaccinated people

Rediff.com14 May 2021

The recommendation holds true for both indoors and outdoors, the CDC said.

Ranbaxy stock ends nearly 4% down post Sun Pharma deal

Ranbaxy stock ends nearly 4% down post Sun Pharma deal

Rediff.com7 Apr 2014

Under terms of the agreed deal, Ranbaxy shareholders will get 0.8 of a Sun Pharmaceutical share for each Ranbaxy share they own.

Gutka sale will soon be a non-bailable offence in Maharashtra

Gutka sale will soon be a non-bailable offence in Maharashtra

Rediff.com23 Mar 2015

The sale of gutka would be booked under non-bailable sections regarding the offence

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

Rediff.com24 Jun 2013

FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.

US court rejects Ranbaxy' plea to block launch by rival cos

US court rejects Ranbaxy' plea to block launch by rival cos

Rediff.com20 Nov 2014

US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.

Sun Pharma seeks shareholders' nod for Rs 12,000-crore QIP

Sun Pharma seeks shareholders' nod for Rs 12,000-crore QIP

Rediff.com12 Sep 2014

Sun Pharma stated the company wanted shareholders' approval to "issue, offer and allot equity shares or non-convertible securities, other than warrants, up to an amount of Rs 12,000 crore ($2 billion), to qualified institutional buyers pursuant to a QIP."

Indian-American physician named co-chair of Biden's Covid task-force

Indian-American physician named co-chair of Biden's Covid task-force

Rediff.com9 Nov 2020

Dr Murthy, 43, a former United States Surgeon General, along with two other co-chairs -- Dr David Kessler and Dr Marcella Nunez-Smith -- would lead a team of leading public health experts who will advise Biden and Vice President-elect Kamala Harris on the deadly virus.

Ranbaxy woes continue to dog Sun Pharma

Ranbaxy woes continue to dog Sun Pharma

Rediff.com29 Oct 2015

The recalled drugs were manufactured and distributed in the US by Ohm Laboratories.

US VP-elect Kamala Harris receives first dose of Moderna COVID-19 vaccine

US VP-elect Kamala Harris receives first dose of Moderna COVID-19 vaccine

Rediff.com30 Dec 2020

The US vice-president-elect received a dose of the Moderna vaccine from clinical nurse Patricia Cummings at United Medical Center, which is located in Southeast Washington, DC.

Sanjay Valvani, New York hedge fund exec found dead in apparent suicide

Sanjay Valvani, New York hedge fund exec found dead in apparent suicide

Rediff.com22 Jun 2016

Prosecutors unveiled charges against Valvani alleging he fraudulently made $25 million by getting advance information about US Food and Drug Administration approvals of generic drug applications

This simple TIP will help you fight coronavirus

This simple TIP will help you fight coronavirus

Rediff.com4 Mar 2020

Meticulous hand washing is your best bet to get rid of the grime that clings to the hand, that might harbour nasty pathogens, including the coronavirus.

US to unveil plans for global distribution of vaccine

US to unveil plans for global distribution of vaccine

Rediff.com2 Jun 2021

In the next two weeks, the United States will detail plans to equitably distribute about 80 million (8 crore) COVID-19 vaccine doses globally without 'political requirements' of those receiving them, Secretary of State Antony Blinken has said.

Trials find Covid vax safe for kids aged 5-11 yrs: Pfizer, BioNTech

Trials find Covid vax safe for kids aged 5-11 yrs: Pfizer, BioNTech

Rediff.com20 Sep 2021

Pfizer and BioNTech SE on Monday said trial results of COVID-19 vaccine showed that it is safe and produced robust neutralising antibody response in children aged five to 11 years, and they plan to seek regulatory approvals as soon as possible.

USFDA issues import alert on Ranbaxy's Mohali plant

USFDA issues import alert on Ranbaxy's Mohali plant

Rediff.com16 Sep 2013

While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.

Regulator finds procedural lapses at Wockhardt's US facility

Regulator finds procedural lapses at Wockhardt's US facility

Rediff.com3 Jun 2014

The FDA had imposed a ban on the company's Waluj plant in May.

Jaishankar 'endeavours' to expand vaccine production with US help

Jaishankar 'endeavours' to expand vaccine production with US help

Rediff.com29 May 2021

Calling COVID-19 pandemic and vaccines as one of the most important aspects of his discussions with top officials of the Biden administration, External Affairs Minister S Jaishankar has said the endeavour is to expand production of vaccines in India with assistance from the US.

Now, Goa bans sale of Maggi; 11th state to ban noodle brand

Now, Goa bans sale of Maggi; 11th state to ban noodle brand

Rediff.com7 Jun 2015

Goa on Sunday joined several other states in banning the sale of Nestle's instant noodle brand 'Maggi' which is at the centre of a raging nationwide row over food safety concerns.

Chemists call for nationwide strike on Oct 14

Chemists call for nationwide strike on Oct 14

Rediff.com1 Oct 2015

The introduction of e-pharmacy, to protect the interest of a handful of players, would hamper the interest of 800,000 chemists and 80 lakh workers and their families

'We put pressure on Biden admn over vaccines'

'We put pressure on Biden admn over vaccines'

Rediff.com13 May 2021

'Supplies should start moving to the Serum Institute without any impediments.'